As of now, BPC-157 has not received approval by the Food and Drug Administration (FDA) for clinical use
One such study in 2012, published in the journal Obesity, found that obese individuals who received vitamin B12 injections lost an average of 3 pounds more than a placebo group over 12 weeks
Side Effects on the Stack The full safety picture lives in the Retatrutide+Cagrilintide Stack Side Effects article
This makes it relevant for inflammation-induced conditions, including eczema, psoriasis, and acne
While this approach likely enhances results, it's not mandatory - the peptide works fine if you inject and then go about your morning without exercise
The peptide will degrade, meaning the concentration of active, correctly structured BPC-157 in your solution will plummet with each passing day